Hepatitis B surface antigen (HBsAg) prevalence (%) in Cape Verde
Cape Verde: Hepatitis B surface antigen (HBsAg) prevalence was 0.7% in 2024. ▼ Falling
Latest (2024)
0.7%
Change on year
up 16.7%
World rank
43rd
of 194 countries
All-time high
1.0%
in 2016
All-time low
0.6%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Cape Verde, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Cape Verde is 0.7%, measured in 2024.
The figure is up 16.7% on the previous year and down 22.2% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Cape Verde peaked at 1.0% in 2016 and was at its lowest, 0.6%, in 2020.
That places Cape Verde 43rd out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Cape Verde, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.9% | — |
| 2016 | 1.0% | +11.1% |
| 2017 | 0.8% | -20.0% |
| 2018 | 0.8% | +0.0% |
| 2019 | 0.7% | -12.5% |
| 2020 | 0.6% | -14.3% |
| 2021 | 0.6% | +0.0% |
| 2022 | 0.6% | +0.0% |
| 2023 | 0.6% | +0.0% |
| 2024 | 0.7% | +16.7% |
Cape Verde compared with similar countries
- Cape Verde's 0.7% is above the median for upper middle income countries, which is 0.2%, 3.5× the median. (57 countries reporting)
- Cape Verde's 0.7% is below the median for Sub-Saharan Africa, which is 1.1%, 67% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.8% | 0.7% | 1.0% | 5 |
| 2020s | 0.6% | 0.6% | 0.7% | 5 |
Countries ranked near Cape Verde
More health data for Cape Verde
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.747 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,578 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -7.87 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0306 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Cape Verde?
- Hepatitis b surface antigen (hbsag) prevalence in Cape Verde was 0.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Cape Verde?
- The highest recorded value was 1.0% in 2016.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Cape Verde?
- The lowest recorded value was 0.6% in 2020.
- How does Cape Verde rank for hepatitis b surface antigen (hbsag) prevalence?
- Cape Verde ranks 43rd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Cape Verde?
- Over the last ten years it is down 22.2%. The long-run trend across the full record is falling.
- Where does this Cape Verde data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).